Egypt E-Pharmacy Market at USD 59M, Chefaa 4.5M Monthly Users, and Yodawy USD 34.5M Raised | Ken Research

Egypt E-Pharmacy and Digital Health Platforms Market at USD 59M, 4.5M Monthly Users, and EGP 309B Pharma Sector: Ken Research

As per Ken Research, the Egypt E-Pharmacy and Digital Health Platforms Market reached USD 59 million in 2024. With 82 million internet users at 72.2% penetration and 96% mobile-first access, Egypt's digital health infrastructure is accelerating. The Egypt E-Pharmacy and Digital Health Platforms Market Report covers segment forecasts and competitive benchmarking through 2030, published by Ken Research.

Sources: Ken Research market modelling, Daily News Egypt (2024), TechCabal (2025), Disrupt Africa (2024), DataReportal Digital 2024 Egypt, and Digital Health Africa (2025).

USD 59M E-Pharmacy Market, EGP 309B Pharma Sector, and 110.5M Mobile Connections Define Egypt's Digital Health Scale

As per Ken Research, Egypt's e-pharmacy and digital health platforms market at USD 59 million (2024) represents approximately 5% of the broader USD 1.2 billion pharma market, signalling large digitization headroom. With 110.5 million active mobile connections (97.3% of population) and 82 million internet users, the digital health infrastructure is firmly in place. The Egypt E-Health and Teleconsultation Platforms Market covers the adjacent teleconsultation segment valued at USD 1.1 billion.

• Market scale: Egypt e-pharmacy and digital health platforms at USD 59 million (2024); broader pharma market EGP 309 billion (+43% YoY); forecast period 2025-2030; pharma grew from EGP 216 billion in 2023.
• Digital infrastructure: 82 million internet users (72.2% penetration); 110.5 million mobile connections; 96% mobile-first internet access.
• Population base: 113.6 million population; 90,000 licensed pharmacies nationwide; 5 million+ teleconsultations conducted; adjacent e-health teleconsultation market at USD 1.1 billion.

Chefaa 4.5M Monthly Users, 1,600+ Pharmacies, and Yodawy USD 34.5M Raised Lead Egypt's Competitive Landscape

As per TechCabal (2025), Chefaa is Egypt's leading e-pharmacy with 4.5 million monthly users, 1,600+ connected pharmacies, and 229 registered brands. Chefaa raised a $5.25 million Series A in 2023 and received $225,000 from the Gates Foundation's Innovate and Invest program in 2025. As per Disrupt Africa (2024), Yodawy has raised USD 34.5 million total. The Egypt E-Pharmacy and Digital Health Platforms Market Report covers the full competitive landscape.

• Chefaa: 4.5 million monthly users; 1,600+ pharmacies; 229 brands; $5.25M Series A (2023); expanded to 8 Saudi cities; commissions from 5% per transaction.
• Yodawy: USD 34.5 million total raised; USD 10M from Ezdehar (2024); pharmacy benefit management plus e-prescription gateway.
• Competitive field: Key players include Vezeeta, 3elagi, Chefaa, Yodawy, Rology, Altibbi, and Ibnsina Pharma; market consolidated from 19 players in 2018 to 3 to 4 major competitors by 2025.

Want segment forecasts, competitive benchmarks, and Egypt digital health channel data through 2030? Download Sample Report to preview the full forecast dataset.

65% Prefer Online Pharmacies, 500 Medicine Types in Shortage, and USD 200M Government Investment Drive Demand

As per Ken Research, 65% of Egyptian consumers prefer online pharmacies for convenience. Egypt's medicine shortage peaked at approximately 1,000 types and remains at approximately 500 types, driven by currency devaluations since 2016, making platforms that locate available stock across 90,000 pharmacies utility-grade infrastructure. Egypt's National Digital Health Strategy 2025-2029, backed by USD 200 million government investment, targets a fully digitized health system by 2029. The Egypt E-Pharmacy and Digital Health Platforms Market Report covers all demand drivers.

• Consumer preference: 65% of consumers prefer online pharmacies; 25 to 30% of population affected by chronic disease; Chefaa's user base grew 300% during COVID-19 lockdowns.
• Government mandate: National Digital Health Strategy 2025-2029 targets full system digitization by 2029; USD 200 million government investment in digital health; 5 million+ teleconsultations conducted.
• Supply gap opportunity: Approximately 500 medicine types still in shortage; 90,000 licensed pharmacy network creates large partner base; Cairo and Alexandria dominate geographic demand.

30% Compliance Rate, 40% Awareness Gap, and Narcotics Ban Define Egypt E-Pharmacy Risks

As per Ken Research, only 30% of e-pharmacies comply with Ministerial Decree No. 238 of 2023, which mandates licensing, pharmacist oversight, and data privacy compliance. Consumer awareness of e-pharmacy services remains limited to approximately 40% of Egypt's population, and approximately 40% of the rural population lacks internet access. The Egypt E-Pharmacy and Digital Health Platforms Market Report covers the full risk and regulatory landscape.

• Regulatory risk: Only 30% compliance with Ministerial Decree No. 238 of 2023; Personal Data Protection Law No. 151 of 2020 imposes patient consent and data security requirements; narcotics and scheduled drugs prohibited on platforms.
• Market access gap: Consumer awareness limited to 40% of population; 40% of rural population without internet access; traditional pharmacies at 90,000 locations compete through physician referrals.
• Regulatory credibility: Egypt awarded WHO Medicines Regulation Maturity Level 3 in December 2024; EDA labs accredited by WHO and EU; 12 international training programs conducted.

Ready for Egypt e-pharmacy competitive landscape, channel forecasts, and CAGR analysis through 2030? Egypt E-Pharmacy and Digital Health Platforms Market Report from Ken Research covers the complete picture.

Conclusion

Egypt's E-Pharmacy and Digital Health Platforms Market at USD 59 million (2024) is driven by Chefaa's 4.5 million monthly users, Yodawy's USD 34.5 million total funding, 65% consumer preference for online pharmacies, USD 200 million government investment, and only 30% regulatory compliance creating consolidation opportunity among 3 to 4 remaining major competitors. Access the Egypt E-Pharmacy and Digital Health Platforms Market Report from Ken Research for full forecasts.

Frequently Asked Questions

Q1: What is the size of the Egypt E-Pharmacy and Digital Health Platforms Market?

As per Ken Research, the market reached USD 59 million in 2024, forecast through 2030, within a broader pharma market of EGP 309 billion (+43% YoY). Full segment data is in the Egypt E-Pharmacy and Digital Health Platforms Market Report.

Q2: Who are the key players in Egypt's e-pharmacy market?

As per Ken Research and TechCabal (2025), Chefaa leads with 4.5 million monthly users and 1,600+ pharmacies. Yodawy has raised USD 34.5 million total and operates pharmacy benefit management. Key players also include Vezeeta, 3elagi, and Rology. The market consolidated from 19 players (2018) to 3 to 4 major competitors by 2025.

Q3: What are the key demand drivers in Egypt's digital health market?

As per Ken Research, 65% of consumers prefer online pharmacies, 82 million internet users provide the addressable base, and 25 to 30% have chronic disease. The National Digital Health Strategy 2025-2029 targets full digitization by 2029 with USD 200 million government investment, and 500 medicine types in shortage drive platform utility.

Q4: What regulations govern Egypt's e-pharmacy market?

As per Ken Research, Ministerial Decree No. 238 of 2023 mandates licensing with pharmacist oversight and data privacy compliance. Personal Data Protection Law No. 151 of 2020 governs health data. Narcotics and scheduled drugs are prohibited on platforms. Only 30% currently comply. Egypt received WHO Medicines Regulation Maturity Level 3 in December 2024.

Q5: What are the key risks in Egypt's e-pharmacy and digital health market?

As per Ken Research, key risks include 30% regulatory compliance, 40% consumer awareness gap, 40% rural internet access gap, and narcotics sales prohibited on platforms. Currency devaluations since 2016 have caused medicine shortages (~500 types). Full risk analysis is in the Egypt E-Pharmacy and Digital Health Platforms Market Report from Ken Research.